Director
GSK
Richard C. Franzese, DPhil, is a Director of Clinical Pharmacology Modeling and Simulation at GSK. He has an interest in model-informed drug development and decision making, with a current focus in oncology. Recently, Richard has utilized model-based meta-analysis (MBMA) and tumour size modeling to predict overall survival at GSK.
Prior to joining GSK, Richard applied quantitative modeling and simulation methods to drug development as a consultant at Certara. Richard has an interest in teaching and mentoring; he spent time teaching high school mathematics before moving into drug development, delivers guest lectures on population PK modeling at UNC Chapel Hill, and mentors within GSK.
Richard was trained as a physicist at the University of Oxford. He focused on biological and condensed matter physics before completing his DPhil in Engineering Science as part of the interdisciplinary Life Sciences Interface Doctoral Training Centre, led by Professor David Gavaghan. Richard also conducted research in Computational Biochemistry and in Materials Science, in addition to his doctoral research which utilized mixed-effects modeling and dynamics systems theory in Biomechanics.
Richard enjoys running, cycling, and cooking in his free time; he was a competitive track and cross-country runner for 10 years, winning the Oxford-Cambridge Varsity Cross Country and Mile races and he spent 6 years coaching track and field.